TCM
MTEM

Tekla Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Tekla Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,295
Closed -$1.56M – 199
2021
Q2 		$1.56M Hold
13,295
– – 0.05% 161
2021
Q1 		$2.52M Sell
13,295
-1,360
-9% -$238K 0.09% 153
2020
Q4 		$2.06M Hold
14,655
– – 0.07% 159
2020
Q3 		$2.4M Buy
14,655
+11,834
+419% +$2.1M 0.09% 143
2020
Q2 		$583K Hold
2,821
– – 0.02% 209
2020
Q1 		$562K Hold
2,821
– – 0.03% 193
2019
Q4 		$592K Sell
2,821
-6,786
-71% -$975K 0.02% 192
2019
Q3 		$950K Hold
9,607
– – 0.04% 161
2019
Q2 		$1.2M Hold
9,607
– – 0.05% 158
2019
Q1 		$837K Hold
9,607
– – 0.03% 167
2018
Q4 		$582K Hold
9,607
– – 0.02% 182
2018
Q3 		$777K Hold
9,607
– – 0.03% 185
2018
Q2 		$754K Buy
9,607
+6,081
+172% +$689K 0.03% 164
2018
Q1 		$423K Buy
+3,526
New +$531K 0.02% 175

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Tekla Capital Management's MTEM Position: Q3 2021 in Review

Tekla Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q3 2021, closing a stake of 13,295 shares — an estimated $1.56M sold.

Tekla Capital Management first reported a position in MTEM in Q1 2018 and held it in 14 quarters. The position peaked at $2.52M in Q1 2021. 86 funds tracked by Wall St. Rank hold MTEM as of Q3 2021.

  • Tekla Capital Management reported no remaining Molecular Templates, Inc. position as of Q3 2021 after selling out during the quarter.
  • Tekla Capital Management sold 13,295 Molecular Templates, Inc. shares in Q3 2021, an estimated $1.56M.
  • Tekla Capital Management first reported a position in Molecular Templates, Inc. in Q1 2018 and held it in 14 quarters.
  • Tekla Capital Management's Molecular Templates, Inc. position peaked at $2.52M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2021.

Based on Tekla Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.